Aethlon Medical, Inc (AEMD) July 20, 2021 Stock Price, Analysis & Forecast
Aethlon Medical, Inc (NASDAQ: AEMD) opened the trading session on July 20, 2021, at $4.56, illustrating a change of 6.8966% against the previous close at $4.93. During the trading session, the stock price rose to $5.27 and dropped to $4.28. Finally, the stock arranged at $5.27. Yet, given a distant prospect, Aethlon Medical, Inc reported a 52 Week Range between $1.219-$7.13.
Aethlon Medical, Inc's shares outstanding currently worth $15.37M, concurrently with a float of $13.88M. AEMD operates in the LIFE SCIENCES sector of the LABORATORY ANALYTICAL INSTRUMENTS industry and has a market capitalization of $80.98M (as of July 20, 2021). Also worth mentioning that Aethlon Medical, Inc's 50-day Moving Average arranged at $4.64, while such sign as 200-day Moving Average is now $2.79.
To evaluate the company's efficiency, let's consider Aethlon Medical, Inc's conglomerate performance. As of today, AEMD has full-time employees. Aethlon Medical, Inc has generated $inf per worker During the last fiscal year. In the meantime, AEMD's income per employee was $inf. And now, let's consider the company's income report. Aethlon Medical, Inc's Net Income for the last fiscal year was $-7,886,709, while such sign as Income Before Taxes was at the level of $-7,886,709. AEMD's Operating Income was at the mark of $-7,889,919.
Aethlon Medical, Inc (AEMD) Earnings & Revenue
Talking about the Profitability, AEMD reached a Profit Margin of 0% and an Operating Margin (TTM) of -1197%. However, when we touch the questions of management effectiveness, Aethlon Medical, Inc generated a Return on Equity (TTM) of -85% and a Return on Assets (TTM) of -46.8%. A bit more income statements might bring clarity to our overview. According to the results of the latest quarter ended March 31, 2021, Aethlon Medical, Inc generated Revenue (TTM) of $659,100, reporting a Quarterly Revenue Growth of -83.4%. As for the Revenue Per Share (TTM), this indicator was at the mark of $0.055. The company's Gross Profit (TTM) was $659,100, while according to the EBITDA report, it was estimated at $-5,969,840.
Aethlon Medical, Inc (NASDAQ: AEMD) Owners & Shares
Finally, let's take a look at the share statistics. As mentioned above, AEMD's shares outstanding now amounts to $15.37M, where Shares Short was $286,510 versus the prior month amounted to $747,200. (Short % of Float was 2.06%). And now, let's overview which kind of investors works with Aethlon Medical, Inc's stocks. AEMD's current ownership accounts for 15.58% institutional investors, while 1.792% of shares belong to the insiders. Also worth mentioning some indicators affecting dividends & splits. Thus, AEMD's Forward Annual Dividend Rate is currently at the mark of 0, whereas the Dividend Yield is 0%, and a Dividend Payout Ratio is 0% (Dividend Date: October 15, 2019). The company's Dividend Per Share sign thereby is $None.
AEMD Trading Performance
It's time to observe the current performance indicators for Aethlon Medical, Inc. AEMD's price/earnings to growth ratio during the last reported quarter was 0%. The company's PE Ratio stands at None%, while AEMD's Beta score is 0.676. Also worth noting that Aethlon Medical, Inc's Diluted EPS (Earnings per Share) trailing twelve months is at the mark of -0.652. Other valuable indicators are Price To Sales Ratio (TTM), which is currently recorded at 90.44, as well as Price To Book Ratio, which amounts to 8.03.
Aethlon Medical, Inc Analysis & Estimates
Within the previous 9-day period, Aethlon Medical, Inc's Average True Range (ATR) was 0.6070, while the stock's Stochastic SlowD moving average was 48.5495%, and the SlowK moving average volumed at 48.5495%.